Understanding the Structure-Function Relationships Between Monoamine Neurotransmitter Transporters and Their Cognate Ions and Ligands

Total Page:16

File Type:pdf, Size:1020Kb

Understanding the Structure-Function Relationships Between Monoamine Neurotransmitter Transporters and Their Cognate Ions and Ligands University of North Dakota UND Scholarly Commons Theses and Dissertations Theses, Dissertations, and Senior Projects January 2015 Understanding The trS ucture-Function Relationships Between Monoamine Neurotransmitter Transporters And Their ogC nate Ions And Ligands Bruce Felts Follow this and additional works at: https://commons.und.edu/theses Recommended Citation Felts, Bruce, "Understanding The trS ucture-Function Relationships Between Monoamine Neurotransmitter Transporters And Their Cognate Ions And Ligands" (2015). Theses and Dissertations. 1769. https://commons.und.edu/theses/1769 This Dissertation is brought to you for free and open access by the Theses, Dissertations, and Senior Projects at UND Scholarly Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of UND Scholarly Commons. For more information, please contact [email protected]. UNDERSTANDING THE STRUCTURE-FUNCTION RELATIONSHIPS BETWEEN MONOAMINE NEUROTRANSMITTER TRANSPORTERS AND THEIR COGNATE IONS AND LIGANDS by Bruce F. Felts Bachelor of Science, University of Minnesota 2009 A dissertation Submitted to the Graduate Faculty of the University of North Dakota in partial fulfillment of the requirements for the degree of Doctor of Philosophy Grand Forks, North Dakota August 2015 Copyright 2015 Bruce Felts ii TABLE OF CONTENTS LIST OF FIGURES………………………………………………………………………... xii LIST OF TABLES……………………….………………………………………………… xv ACKNOWLEDGMENTS.…………………………………………………………….… xvi ABSTRACT.………………………………………………………………………….……. xviii CHAPTERS I. INTRODUCTION.………………………………………………………………… 1 The Solute Carrier Super-family of Proteins………………………………. 1 The Neurophysiologic Role of MATs……………………………………... 2 Monoamine Transporter Structure…………………………………………. 5 The Substrate Binding Pocket……………………………………… 10 The S1 binding site in LeuT………………………………... 11 The S1 binding site in MATs………………………………. 13 The S2 binding site in the extracellular vestibule………….. 14 Ion Binding Sites in MATs………………………………………… 17 The Na+ binding sites………………………………………. 17 The Cl– binding site………………………………………... 20 Chemiosmotic Coupling and the Translocation Mechanism………………. 22 The Alternating Access Mechanism of Substrate Transport………. 22 Kinetic and Electrogenic Properties of MATs……………………... 26 v Pharmacological Intervention and MATs…………………...……………... 28 II. A CONSERVED ASPARAGINE RESIDUE IN TRANSMEMBRANE SEGMENT ONE OF THE SEROTONIN TRANSPORTER DICTATES CHLORIDE-COUPLED NEUROTRANSMITTER TRANSPORT……………… 32 Introduction………………………………………………………………… 32 Methodology……………………………………………………………….. 34 Site-directed Mutagenesis and Construction of Mutant Plasmids…. 34 5-HT and NE Transport Measurements……………………………. 34 Spontaneous 5-HT Efflux………………………………………….. 36 Total and Cell Surface Expression Protein Analysis………………. 36 Evaluation of Cysteine Accessibility………………………………. 37 hSERT Expression in Xenopus laevis Oocytes……………………. 38 Simultaneous Measurement of 5-HT Uptake and 5-HT-induced Currents…………………………………………………………….. 39 hSERT Molecular Modeling……………………………………….. 39 Molecular Dynamics and Free Energy Perturbation (FEP) Simulations………………………………………………………… 41 Results……………………………………………………………………… 42 hSERT N101 Mutation Eliminates Cl− Dependence of 5-HT Uptake……………………………………………………………… 42 N101 Dictates Cl−-Dependent Conformational Changes in TM1 and EL4…………………………………………………………….. 44 hSERT N101 Dictates Ion Selectivity of 5-HT-independent Charge Flux………………………………………………………………… 48 N101 Dictates Cl− Dependence of 5-HT-induced Currents………... 52 vi N101 Dictates hSERT Coupling and Stoichiometry………………. 54 Molecular Modeling Suggests a Mechanism for N101 Participation in Ion-Coupled 5-HT Transport……………………………………. 56 Effect of Cl− and Different Mutations on Ion and Solute Binding to the Transporter……………………………………………………... 60 Validation of the Partnership Between N101 and S336 in Cl−- Dependent 5-HT Transport………………………………………… 61 Discussion………………………………………………………………….. 67 III. THE TWO SODIUM SITES IN THE SEROTONIN TRANSPORTER PLAY DISTINCT ROLES IN THE ION COUPLING AND ELECTROGENICITY OF TRANSPORT……………………………………………………………………… 74 Introduction………………………………………………………………… 74 Methodology……………………………………………………………….. 77 Site-Directed Mutagenesis…………………………………………. 77 5-HT Uptake Analysis……………………………………………... 77 Protein Expression Analysis……………………………………….. 78 Cysteine Accessibility Analysis……………………………………. 79 Two-Electrode Voltage Clamp Analysis…………………………... 79 cRNA preparation………………………………………….. 79 Oocyte preparation…………………………………………. 79 Electrophysiological recordings in X. laevis oocytes……… 80 Whole Cell Patch Clamp…………………………………………… 80 Molecular Dynamic (MD) Simulations of hSERT·5-HT·Ion Complexes………………………………………………………….. 81 Results……………………………………………………………………… 84 vii N101 Mutation Specifically Modifies Cation Dependence, Allowing Ca2+ to Functionally Replace Na+ for 5-HT Transport….. 84 Na+, but Not Ca2+, Imparts Conformational Changes in Native hSERT, whereas Both Na+ and Ca2+ Can Promote 5-HT-Induced Conformational Changes in the N101A Mutant…………………… 87 hSERT N101 Mutants Display a Loss of Potency for Na+ to Drive 5-HT Transport…………………………………………………….. 89 Mutation at N101 Diminishes the Ability of the Transporter to Concentrate 5-HT…………………………………………………... 92 Ca2+ Decreases the Apparent Affinity of 5-HT in both hSERT and the N101 Mutants…………………………………………………... 92 Mutations at Na2 Site Fail to Alter Cation Selectivity…………….. 93 The Na1 Site Does Not Contribute to the Substrate-induced or Leak Currents in hSERT…………………………………………… 96 Whole Cell Clamp of the N101A Mutant in HEK293 Cells Suggests That Cl− Is the Main Charge Carrier When External Na+ Is Substituted by Ca2+…………………………………………. 100 hSERT N101 Mutants Appear to Function as both Active and Passive Transporters……………………………………………….. 101 Molecular Dynamics Simulations Suggest a Mechanism for Ca2+ Gain-of-Function Phenotype…………………………………. 103 Discussion………………………………………………………………….. 109 IV. ANTAGONIST-INDUCED CONFORMATIONAL CHANGES IN DOPAMINE TRANSPORTER EXTRACELLULAR LOOP TWO INVOLVE RESIDUES IN A POTENTIAL SALT BRIDGE…………………………………………………... 118 Introduction………………………………………………………………… 118 Methodology……………………………………………………………….. 122 Tissue Preparation and Proteolysis………………………………… 122 viii Immunoblot Analysis………………………………………………. 123 Quantification of DAT Proteolysis………………………………… 123 Deglycosylation Analysis………………………………………….. 124 Asp-N Activity Assay……………………………………………… 124 [3H]CFT Binding and [3H]DA Uptake…………………………….. 124 SCAM Analysis……………………………………………………. 125 Molecular Modeling………………………………………………... 127 Results……………………………………………………………………… 128 Endoproteinase Asp-N Digestion of rDAT………………………… 128 Uptake Blockers Reduce Asp-N Proteolysis………………………. 130 Asp-N Treatment Disrupts DAT Function………………………… 132 SCAM Analysis of EL2 Residues…………………………………. 134 Molecular Modeling………………………………………………... 140 Discussion………………………………………………………………….. 143 V. THE FORMATION OF A PUTATIVE SALT BRIDGE AT THE EXTERNAL GATE OF THE SEROTONIN TRANSPORTER IS IMPORTANT FOR AMPHETAMINE TRANSLOCATION AND THE INDUCTION OF SUBSTRATE EFFLUX…………………………………………………………… 148 Introduction………………………………………………………………… 148 Methodology……………………………………………………………….. 151 Site-Directed Mutagenesis…………………………………………. 151 [3H]5-HT Uptake Assay……………………………………………. 151 Surface Expression Analysis via Surface Biotinylation…………… 153 ix Whole-Cell Radioligand Binding Assay…………………………… 153 Two-electrode Voltage Clamping of Xenopus Oocytes…………... 153 cRNA preparation………………………………………….. 153 Oocyte preparation…………………………………………. 154 Electrophysiological recordings in X. laevis oocytes……… 154 Results……………………………………………………………………… 155 Disruption of hSERT External Gate Abolishes Transport…………. 155 Species-Scanning Mutagenesis of the External Gate Yields Little Effect on 5-HT Transport or Protein Trafficking…..…………….... 155 The Acidic TM10 Gating Residue is Important for the Ability of the Transporter to Mediate MDMA-Induced Efflux………………. 158 Mutation at the Outer Gate does not Significantly Alter MDMA Potency……………………………………………………………... 161 The Generation of MDMA-Induced Current by SERT is Dependent on the Presence of the Acidic TM10 Gating Residue…. 164 Discussion………………………………………………………………….. 168 VI. NOVEL AZIDO-IODO PHOTOAFFINITY LIGANDS FOR THE SEROTONIN TRANSPORTER BASED ON THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (S)-CITALOPRAM………………………………………………….. 177 Introduction………………………………………………………………… 177 Methodology……………………………………………………………….. 182 Whole-cell Competition Uptake Assay……………………………. 182 hSERT Photoaffinity Labeling…………………………………….. 182 Results……………………………………………………………………… 183 Pharmacological Properties of NYDU-2-24, VK-03-51 and VK- 03-83……………………………………………………………….. 183 x Photoaffinity Labeling Experiments with hSERT…………………. 184 Discussion………………………………………………………………….. 189 REFERENCES…………………………………………………………………….. 192 xi LIST OF FIGURES Figure Page(s) 1. Role of MATs in Synaptic Transmission…………………………………………. 3 2. Basic structure of a MAT…………………………………………………………. 7 3. X-ray crystal structure and topology of the SLC6 bacterial homologue, LeuT…... 8 4. The S1 binding site of LeuT, dDAT and hSERT…………………………………. 12 5. The location of the S1 and S2 binding sites in LeuT……………………………… 15 6. The ion binding sites in LeuT, dDAT and hSERT………………………………... 19 7. The alternating access model of transport………………………………………… 23 8. Three distinct structural conformations of LeuT provide a general outline of the alternating access mechanism of transport………………………………………... 25 9. Chemical structures of classic MAT substrates and inhibitors………………...….. 29 10. Kinetic analysis and Cl– dependence of 5-HT uptake in hSERT N101
Recommended publications
  • Impact of Using Organic Yeast in the Fermentation Process of Wine
    processes Article Impact of Using Organic Yeast in the Fermentation Process of Wine Balázs Nagy 1, Zsuzsanna Varga 2,Réka Matolcsi 1, Nikolett Kellner 1 , Áron Szövényi 1 and Diána Nyitrainé Sárdy 1,* 1 Faculty of Horticultural Science Department of Oenology, Szent István University, 1118 Budapest, Hungary; [email protected] (B.N.); [email protected] (R.M.); [email protected] (N.K.); [email protected] (Á.S.) 2 Faculty of Horticultural Science Department of Viticulture, Szent István University, 1118 Budapest, Hungary; [email protected] * Correspondence: [email protected] Abstract: The aim of this study was to find out what kind of “Bianca” wine could be produced when using organic yeast, what are the dynamics of the resulting alcoholic fermentation, and whether this method is suitable for industrial production as well. Due to the stricter rules and regulations, as well as the limited amount and selection of the permitted chemicals, resistant, also known as interspecific or innovative grape varieties, can be the ideal basic materials of alternative cultivation technologies. Well-designed analytical and organoleptic results have to provide the scientific background of resistant varieties, as these cultivars and their environmentally friendly cultivation techniques could be the raw materials of the future. The role of the yeast in wine production is crucial. We fermented wines from the “Bianca” juice samples three times where model chemical solutions were applied. In our research, we aimed to find out how organic yeast influenced the biogenic amine formation of three important compounds: histamine, tyramine, and serotonin. The main results of this study showed that all the problematic values (e.g., histamine) were under the critical limit (1 g/L), although the organic samples resulted in a significantly higher level than the control wines.
    [Show full text]
  • Iron Transport Proteins: Gateways of Cellular and Systemic Iron Homeostasis
    Iron transport proteins: Gateways of cellular and systemic iron homeostasis Mitchell D. Knutson, PhD University of Florida Essential Vocabulary Fe Heme Membrane Transport DMT1 FLVCR Ferroportin HRG1 Mitoferrin Nramp1 ZIP14 Serum Transport Transferrin Transferrin receptor 1 Cytosolic Transport PCBP1, PCBP2 Timeline of identification in mammalian iron transport Year Protein Original Publications 1947 Transferrin Laurell and Ingelman, Acta Chem Scand 1959 Transferrin receptor 1 Jandl et al., J Clin Invest 1997 DMT1 Gunshin et al., Nature; Fleming et al. Nature Genet. 1999 Nramp1 Barton et al., J Leukocyt Biol 2000 Ferroportin Donovan et al., Nature; McKie et al., Cell; Abboud et al. J. Biol Chem 2004 FLVCR Quigley et al., Cell 2006 Mitoferrin Shaw et al., Nature 2006 ZIP14 Liuzzi et al., Proc Natl Acad Sci USA 2008 PCBP1, PCBP2 Shi et al., Science 2013 HRG1 White et al., Cell Metab DMT1 (SLC11A2) • Divalent metal-ion transporter-1 • Former names: Nramp2, DCT1 Fleming et al. Nat Genet, 1997; Gunshin et al., Nature 1997 • Mediates uptake of Fe2+, Mn2+, Cd2+ • H+ coupled transporter (cotransporter, symporter) • Main roles: • intestinal iron absorption Illing et al. JBC, 2012 • iron assimilation by erythroid cells DMT1 (SLC11A2) Yanatori et al. BMC Cell Biology 2010 • 4 different isoforms: 557 – 590 a.a. (hDMT1) Hubert & Hentze, PNAS, 2002 • Function similarly in iron transport • Differ in tissue/subcellular distribution and regulation • Regulated by iron: transcriptionally (via HIF2α) post-transcriptionally (via IRE) IRE = Iron-Responsive Element Enterocyte Lumen DMT1 Fe2+ Fe2+ Portal blood Enterocyte Lumen DMT1 Fe2+ Fe2+ Fe2+ Fe2+ Ferroportin Portal blood Ferroportin (SLC40A1) • Only known mammalian iron exporter Donovan et al., Nature 2000; McKie et al., Cell 2000; Abboud et al.
    [Show full text]
  • (Ssris) SEROTONIN and NOREPHINEPHRINE REUPTAKE INHIBITORS DOPAMINE and NOREPINEPHRINE RE
    VA / DOD DEPRESSION PRACTICE GUIDELINE PROVIDER CARE CARD ANTIDEPRESSANT MEDICATION TABLE CARD 7 Refer to pharmaceutical manufacturer’s literature for full prescribing information SEROTONIN SELECTIVE REUPTAKE INHIBITORS (SSRIs) GENERIC BRAND NAME ADULT STARTING DOSE MAX EXCEPTION SAFETY MARGIN TOLERABILITY EFFICACY SIMPLICITY Citalopram Celexa 20 mg 60 mg Reduce dose Nausea, insomnia, Fluoxetine Prozac 20 mg 80 mg for the elderly & No serious systemic sedation, those with renal toxicity even after headache, fatigue Paroxetine Paxil 20 mg 50 mg or hepatic substantial overdose. dizziness, sexual AM daily dosing. failure Drug interactions may dysfunction Response rate = Can be started at Sertraline Zoloft 50 mg 200 mg include tricyclic anorexia, weight 2 - 4 wks an effective dose First Line Antidepressant Medication antidepressants, loss, sweating, GI immediately. Drugs of this class differ substantially in safety, tolerability and simplicity when used in patients carbamazepine & distress, tremor, warfarin. restlessness, on other medications. Can work in TCA (tricyclic antidepressant) nonresponders. Useful in agitation, anxiety. several anxiety disorders. Taper gradually when discontinuing these medications. SEROTONIN and NOREPHINEPHRINE REUPTAKE INHIBITORS GENERIC BRAND NAME ADULT STARTING DOSE MAX EXCEPTION SAFETY MARGIN TOLERABILITY EFFICACY SIMPLICITY Reduce dose Take with food. Venlafaxine IR Effexor IR 75 mg 375 mg Comparable to BID or TID for the elderly & No serious systemic SSRIs at low dose. dosing with IR. those with renal toxicity. Nausea, dry mouth, Response rate = Daily dosing or hepatic Downtaper slowly to Venlafaxine XR Effexor XR 75 mg 375 mg insomnia, anxiety, 2 - 4 wks with XR. failure prevent clinically somnolence, head- (4 - 7 days at Can be started at significant withdrawal ache, dizziness, ~300 mg/day) an effective dose Dual action drug that predominantly acts like a Serotonin Selective Reuptake inhibitor at low syndrome.
    [Show full text]
  • Biogenic Amines Formation and Their Importance in Fermented Foods
    BIO Web of Conferences 17, 00232 (2020) https://doi.org/10.1051/bioconf/20201700232 FIES 2019 Biogenic amines formation and their importance in fermented foods Kamil Ekici1, ⃰ and Abdullah Khalid Omer2 1University of Van Yȕzȕncȕ Yıl, Veterinary College, Department of Food Hygiene and Technology, Van, Turkey 2Sulaimani Veterinary Directorate, Veterinary Quarantine, Bashmakh International Border, Sulaimani, Iraq Abstract. Biogenic amines (BAs) are low molecular weight organic bases with an aliphatic, aromatic, or heterocyclic structure which have been found in many foods. biogenic amines have been related with several outbreaks of food-borne intoxication and are very important in public health concern because of their potential toxic effects. The accumulation of biogenic amines in foods is mainly due to the presence of bacteria able to decarboxylate certain amino acids. Biogenic amines are formed when the alpha carboxvl group breaks away from free amino acid precursors. They are colled after the amino acid they originated from. The main biogenic amines producers in foods are Gram positive bacteria and cheese is among the most commonly implicated foods associated with biogenic amines poisoning. The consumption of foods containing high concentrations of biogenic amines has been associated with health hazards and they are used as a quality indicator that shows the degree of spoilage, use of non-hygienic raw material and poor manufacturing practice. Biogenic amines may also be considered as carcinogens because they are able to react with nitrites to form potentially carcinogenic nitrosamines. Generally, biogenic amines in foods can be controlled by strict use of good hygiene in both raw material and manufacturing environments with corresponding inhibition of spoiling microorganisms.
    [Show full text]
  • Effect of Hydrolyzable Tannins on Glucose-Transporter Expression and Their Bioavailability in Pig Small-Intestinal 3D Cell Model
    molecules Article Effect of Hydrolyzable Tannins on Glucose-Transporter Expression and Their Bioavailability in Pig Small-Intestinal 3D Cell Model Maksimiljan Brus 1 , Robert Frangež 2, Mario Gorenjak 3 , Petra Kotnik 4,5, Željko Knez 4,5 and Dejan Škorjanc 1,* 1 Faculty of Agriculture and Life Sciences, University of Maribor, Pivola 10, 2311 Hoˇce,Slovenia; [email protected] 2 Veterinary Faculty, Institute of Preclinical Sciences, University of Ljubljana, Gerbiˇceva60, 1000 Ljubljana, Slovenia; [email protected] 3 Center for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, Taborska 8, 2000 Maribor, Slovenia; [email protected] 4 Department of Chemistry, Faculty of Medicine, University of Maribor, Taborska 8, 2000 Maribor, Slovenia; [email protected] (P.K.); [email protected] (Ž.K.) 5 Laboratory for Separation Processes and Product Design, Faculty of Chemistry and Chemical Engineering, University of Maribor, Smetanova 17, 2000 Maribor, Slovenia * Correspondence: [email protected]; Tel.: +386-2-320-90-25 Abstract: Intestinal transepithelial transport of glucose is mediated by glucose transporters, and affects postprandial blood-glucose levels. This study investigates the effect of wood extracts rich in hydrolyzable tannins (HTs) that originated from sweet chestnut (Castanea sativa Mill.) and oak (Quercus petraea) on the expression of glucose transporter genes and the uptake of glucose and HT constituents in a 3D porcine-small-intestine epithelial-cell model. The viability of epithelial cells CLAB and PSI exposed to different HTs was determined using alamarBlue®. qPCR was used to analyze the gene expression of SGLT1, GLUT2, GLUT4, and POLR2A. Glucose uptake was confirmed Citation: Brus, M.; Frangež, R.; by assay, and LC–MS/ MS was used for the analysis of HT bioavailability.
    [Show full text]
  • Selective Serotonin Reuptake Inhibitors, Fluoxetine and Paroxetine, Attenuate the Expression of the Established Behavioral Sensitization Induced by Methamphetamine
    Neuropsychopharmacology (2007) 32, 658–664 & 2007 Nature Publishing Group All rights reserved 0893-133X/07 $30.00 www.neuropsychopharmacology.org Selective Serotonin Reuptake Inhibitors, Fluoxetine and Paroxetine, Attenuate the Expression of the Established Behavioral Sensitization Induced by Methamphetamine 1 1 1 1 1 ,1 Yujiro Kaneko , Atsushi Kashiwa , Takashi Ito , Sumikazu Ishii , Asami Umino and Toru Nishikawa* 1 Section of Psychiatry and Behavioral Sciences, Tokyo Medical and Dental University Graduate School, Yushima, Bunkyo-ku, Tokyo, Japan To obtain an insight into the development of a new pharmacotherapy that prevents the treatment-resistant relapse of psychostimulant- induced psychosis and schizophrenia, we have investigated in the mouse the effects of selective serotonin reuptake inhibitors (SSRI), fluoxetine (FLX) and paroxetine (PRX), on the established sensitization induced by methamphetamine (MAP), a model of the relapse of these psychoses, because the modifications of the brain serotonergic transmission have been reported to antagonize the sensitization phenomenon. In agreement with previous reports, repeated MAP treatment (1.0 mg/kg a day, subcutaneously (s.c.)) for 10 days induced a long-lasting enhancement of the increasing effects of a challenge dose of MAP (0.24 mg/kg, s.c.) on motor activity on day 12 or 29 of withdrawal. The daily injection of FLX (10 mg/kg, s.c.) or PRX (8 mg/kg, s.c.) from 12 to 16 days of withdrawal of repeated MAP administration markedly attenuated the ability of the MAP pretreatment to augment the motor responses to the challenge dose of the stimulant 13 days after the SSRI injection. The repeated treatment with FLX or PRX alone failed to affect the motor stimulation following the challenge of saline and MAP 13 days later.
    [Show full text]
  • Discovery of Novel Imidazolines and Imidazoles As Selective TAAR1
    Discovery of Novel Imidazolines and Imidazoles as Selective TAAR1 Partial Agonists for the Treatment of Psychiatric Disorders Giuseppe Cecere, pRED, Discovery Chemistry F. Hoffmann-La Roche AG, Basel, Switzerland Biological Rationale Trace amines are known for four decades Trace Amines - phenylethylamine p- tyramine p- octopamine tryptamine (PEA) Biogenic Amines dopamine norepinephrine serotonin ( DA) (NE) (5-HT) • Structurally related to classical biogenic amine neurotransmitters (DA, NE, 5-HT) • Co-localised & released with biogenic amines in same cells and vesicles • Low concentrations in CNS, rapidly catabolized by monoamine oxidase (MAO) • Dysregulation linked to psychiatric disorders such as schizophrenia & 2 depression Trace Amines Metabolism 3 Biological Rationale Trace Amine-Associated Receptors (TAARs) p-Tyramine extracellular TAAR1 Discrete family of GPCR’s Subtypes TAAR1-TAAR9 known intracellular Gs Structural similarity with the rhodopsin and adrenergic receptor superfamily adenylate Activation of the TAAR1 cyclase receptor leads to cAMP elevation of intracellular cAMP levels • First discovered in 2001 (Borowsky & Bunzow); characterised and classified at Roche in 2004 • Trace amines are endogenous ligands of TAAR1 • TAAR1 is expressed throughout the limbic and monoaminergic system in the brain Borowsky, B. et al., PNAS 2001, 98, 8966; Bunzow, J. R. et al., Mol. Pharmacol. 2001, 60, 1181. Lindemann L, Hoener MC, Trends Pharmacol Sci 2005, 26, 274. 4 Biological Rationale Electrical activity of dopaminergic neurons + p-tyramine
    [Show full text]
  • Biogenic Amine Reference Materials
    Biogenic Amine reference materials Epinephrine (adrenaline), Vanillylmandelic acid (VMA) and homovanillic norepinephrine (noradrenaline) and acid (HVA) are end products of catecholamine metabolism. Increased urinary excretion of VMA dopamine are a group of biogenic and HVA is a diagnostic marker for neuroblastoma, amines known as catecholamines. one of the most common solid cancers in early childhood. They are produced mainly by the chromaffin cells in the medulla of the adrenal gland. Under The biogenic amine, serotonin, is a neurotransmitter normal circumstances catecholamines cause in the central nervous system. A number of disorders general physiological changes that prepare the are associated with pathological changes in body for fight-or-flight. However, significantly serotonin concentrations. Serotonin deficiency is raised levels of catecholamines and their primary related to depression, schizophrenia and Parkinson’s metabolites ‘metanephrines’ (metanephrine, disease. Serotonin excess on the other hand is normetanephrine, and 3-methoxytyramine) are attributed to carcinoid tumours. The determination used diagnostically as markers for the presence of of serotonin or its metabolite 5-hydroxyindoleacetic a pheochromocytoma, a neuroendocrine tumor of acid (5-HIAA) is a standard diagnostic test when the adrenal medulla. carcinoid syndrome is suspected. LGC Quality - ISO Guide 34 • GMP/GLP • ISO 9001 • ISO/IEC 17025 • ISO/IEC 17043 Reference materials Product code Description Pack size Epinephrines and metabolites TRC-E588585 (±)-Epinephrine
    [Show full text]
  • Renal Membrane Transport Proteins and the Transporter Genes
    Techno e lo n g Gowder, Gene Technology 2014, 3:1 e y G Gene Technology DOI; 10.4172/2329-6682.1000e109 ISSN: 2329-6682 Editorial Open Access Renal Membrane Transport Proteins and the Transporter Genes Sivakumar J T Gowder* Qassim University, College of Applied Medical Sciences, Buraidah, Kingdom of Saudi Arabia Kidney this way, high sodium diet favors urinary sodium concentration [9]. AQP2 has a role in hereditary and acquired diseases affecting urine- In humans, the kidneys are a pair of bean-shaped organs about concentrating mechanisms [10]. AQP2 regulates antidiuretic action 10 cm long and located on either side of the vertebral column. The of arginine vasopressin (AVP). The urinary excretion of this protein is kidneys constitute for less than 1% of the weight of the human body, considered to be an index of AVP signaling activity in the renal system. but they receive about 20% of blood pumped with each heartbeat. The Aquaporins are also considered as markers for chronic renal allograft renal artery transports blood to be filtered to the kidneys, and the renal dysfunction [11]. vein carries filtered blood away from the kidneys. Urine, the waste fluid formed within the kidney, exits the organ through a duct called the AQP4 ureter. The kidney is an organ of excretion, transport and metabolism. This gene encodes a member of the aquaporin family of intrinsic It is a complicated organ, comprising various cell types and having a membrane proteins. These proteins function as water-selective channels neatly designed three dimensional organization [1]. Due to structural in the plasma membrane.
    [Show full text]
  • Aminergic Transmitter Systems in Cognitive Disorders
    AMINERGIC TRANSMITTER SYSTEMS IN COGNITIVE DISORDERS John P. Bruno1 and Martin Sarter Departments of Psychology and Neuroscience, The Ohio State University Columbus, OH 43210 Running title: Cognitive disorders and aminergic transmission 1 Correspondence: Dr. John P. Bruno Department of Psychology 31 Townshend Hall The Ohio State University Columbus, OH 43210 voice: 614-292-1770 FAX: 614-688-4733 email: [email protected] To appear in: Textbook of Biological Psychiatry (D haenen H, Den Boer JA, Westenberg H, Willner P, eds.), John Wiley and Sons. INTRODUCTION 2 The major categories of cognitive disorders defined in the DSMIV include various types of dementias, deliriums, and amnestic disorders (American Psychological Association, DSMIV, 2000). The goal of this chapter is to present a thorough, but certainly not exhaustive, summary of the evidence for dysregulations in aminergic neurotransmitter systems in several representative cognitive disorders. Aminergic transmitter systems include the biogenic amine acetylcholine (ACh), the catecholamines dopamine (DA), norepinephrine (NE), epinephrine (Epi), and the indoleamine serotonin (5-HT). For a more detailed discussion of the neuropharmacology and chemoanatomy of aminergic transmitter systems the reader is referred to the earlier chapter by Mathé and Svensson in this book. Not surprisingly, there is considerable variation in the extent of the literatures on the neurochemical dysregulations accompanying delirium, dementia, and amnestic disorders. The scope of our review will be limited to several syndromes for which there is considerable evidence implicating specific aminergic transmitter systems to these cognitive disorders. Thus, the discussion of the dementias will be limited to dementia of the Alzheimer s type (DAT) and AIDS-associated dementia (AAD).
    [Show full text]
  • REVIEW the Molecular Basis of Insulin
    1 REVIEW The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and potential drug targets Sophie E Leney and Jeremy M Tavare´ Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol BS8 1TD, UK (Correspondence should be addressed to J M Tavare´; Email: [email protected]) Abstract The search for the underlying mechanism through which GLUT4 translocation and will attempt to address the spatial insulin regulates glucose uptake into peripheral tissues has relationship between the signalling and trafficking com- unveiled a highly intricate network of molecules that function ponents of this event. We will also explore the degree to in concert to elicit the redistribution or ‘translocation’ of which components of the insulin signalling and GLUT4 the glucose transporter isoform GLUT4 from intracellular trafficking machinery may serve as potential targets for membranes to the cell surface. Following recent technological the development of orally available insulin mimics for the advances within this field, this review aims to bring together treatment of diabetes mellitus. the key molecular players that are thought to be involved in Journal of Endocrinology (2009) 203, 1–18 Introduction Levine & Goldstein 1958). However, the mechanism by which insulin is able to stimulate glucose uptake was not Glucose homeostasis and diabetes mellitus elucidated until the early 1980s when two independent groups demonstrated that insulin promoted the movement of The ability of insulin to stimulate glucose uptake into muscle and adipose tissue is central to the maintenance of whole- a ‘glucose transport activity’ from an intracellular membrane body glucose homeostasis. Autoimmune destruction of the pool to the plasma membrane (Cushman & Wardzala 1980, pancreatic b-cells results in a lack of insulin production Suzuki & Kono 1980).
    [Show full text]
  • Expression of Neurotransmitter Transport from Rat Brain Mrna in Xenopus Laevis Oocytes RANDY D
    Proc. Natl. Acad. Sci. USA Vol. 85, pp. 9846-9850, December 1988 Neurobiology Expression of neurotransmitter transport from rat brain mRNA in Xenopus laevis oocytes RANDY D. BLAKELY*, MICHAEL B. ROBINSONt, AND SUSAN G. AMARA* *Section of Molecular Neurobiology, Howard Hughes Medical Institute Research Laboratories, Yale University School of Medicine, 333 Cedar Street, P.O. Box 3333, New Haven, CT 06510; and tDepartments of Pediatrics and Pharmacology, Children's Seashore House, Philadelphia, PA 19104 Communicated by Charles F. Stevens, October 3, 1988 ABSTRACT To permit a molecular characterization of presently employed in our society, including cocaine, am- neurotransmitter transporter proteins, we have studied uptake phetamines, and tricyclic antidepressants (10, 11). activities induced in Xenopus laevis oocytes after injection of In sharp contrast to the detail with which other proteins adult rat forebrain, cerebellum, brainstem, and spinal cord involved in signal transduction are understood, and despite a poly(A)+ RNA. L-Glutamate uptake could be observed as early wealth of bioenergetic and kinetic studies on transport itself as 24 hr after injection, was linearly related to the quantity of (12, 13), our understanding ofthe molecular principles guiding mRNA injected, and could be induced after injection ofas little neurotransmitter uptake is considerably limited. Due, per- as 1 ng of cerebellar mRNA. Transport of radiolabeled haps, to their low abundance and poor stability in vitro (14), L-glutamate, y-aminobutyric acid, glycine, dopamine, seroto- purification strategies have as yet yielded little structural data. nin, and choline could be measured in single microinjected Only within the past few years has a Na'-dependent GABA oocytes with a regional profile consistent with the anatomical transporter from rat brain been reconstituted and purified (15).
    [Show full text]